Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? (Q34032598)

30 July 2017

title

Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? (English)

1 reference

30 July 2017

7

Jiaoti Huang

1 reference

30 July 2017

Jim C Hu

1

1 reference

30 July 2017

Edward Chang

2

1 reference

30 July 2017

Shyam Natarajan

3

1 reference

30 July 2017

Daniel J Margolis

4

1 reference

30 July 2017

Malu Macairan

5

1 reference

30 July 2017

Patricia Lieu

6

1 reference

30 July 2017

Geoffrey Sonn

8

1 reference

30 July 2017

Frederick J Dorey

9

1 reference

30 July 2017

Leonard S Marks

10

1 reference

30 July 2017

language of work or name

English

0 references

publication date

8 February 2014

1 reference

30 July 2017

1 reference

30 July 2017

volume

192

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

385-390

1 reference

Gleason grade progression is uncommon

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Active surveillance for prostate cancer: a systematic review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

ESUR prostate MR guidelines 2012

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Clinical application of a 3D ultrasound-guided prostate biopsy system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Active surveillance for the management of prostate cancer in a contemporary cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4129939

Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study

29 October 2018

1 reference

12 December 2020

The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy

1 reference

12 December 2020

Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men

1 reference

12 December 2020

Perfecting nerve-sparing radical prostatectomy: sailing in uncharted waters

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study

1 reference

12 December 2020

10.1016/J.JURO.2014.02.005

Identifiers

DOI

1 reference

release_eef457h6rfezfhpllzquzyjhpe

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eef457h6rfezfhpllzquzyjhpe

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4129939

1 reference

30 July 2017

1 reference